Optimisation of a series of potent, selective and orally bioavailable GlyT1 inhibitors von Thomson, Joanne L., Blackaby, Wesley P., Jennings, Andrew S.R., Goodacre, Simon C., Pike, Andrew, Thomas, Steve, Brown, Terry A., Smith, Alison, Pillai, Gopalan, Street, Leslie J., Lewis, Richard T.

Volltext

Identification of an Orally Bioavailable, Potent, and Selective Inhibitor of GlyT1 von Blackaby, Wesley P, Lewis, Richard T, Thomson, Joanne L, Jennings, Andrew S. R, Goodacre, Simon C, Street, Leslie J, MacLeod, Angus M, Pike, Andrew, Wood, Suzanne, Thomas, Steve, Brown, Terry A, Smith, Alison, Pillai, Gopalan, Almond, Sarah, Guscott, Martin R, Burns, H. Donald, Eng, Waisi, Ryan, Christine, Cook, Jacquelynn, Hamill, Terence G

Volltext

A Pyridazine Series of α2/α3 Subtype Selective GABAA Agonists for the Treatment of Anxiety von Lewis, Richard T., Blackaby, Wesley P., Blackburn, Timothy, Jennings, Andrew S. R., Pike, Andrew, Wilson, Rowan A., Hallett, David J., Cook, Susan M., Ferris, Pushpinder, Marshall, George R., Reynolds, David S., Sheppard, Wayne F. A., Smith, Alison J., Sohal, Bindi, Stanley, Joanna, Tye, Spencer J., Wafford, Keith A., Atack, John R.

Volltext

Imidazo[1,2-b][1,2,4]triazines as α2/α3 subtype selective GABAA agonists for the treatment of anxiety von Jennings, Andrew S.R., Lewis, Richard T., Russell, Michael G.N., Hallett, David J., Street, Leslie J., Castro, José L., Atack, John R., Cook, Susan M., Lincoln, Rachael, Stanley, Joanna, Smith, Alison J., Reynolds, David S., Sohal, Bindi, Pike, Andrew, Marshall, George R., Wafford, Keith A., Sheppard, Wayne F.A., Tye, Spencer J.

Volltext